David I. Lichter

Executive Director, Clinical Research / Clinical Science & Program Lead For Ser-155 at Seres Therapeutics

David I. Lichter is currently the Executive Director at Seres Therapeutics, leading the clinical research and science programs for SER-155, SER-287, and SER-301. Prior to this, David I. held positions at Lock Horns LLC, Leica Biosystems, and Millennium: The Takeda Oncology Company, where David I. focused on clinical research, assay development, and biomarker analysis. David holds a Bachelor of Science in Cell & Developmental Biology and an ALM in Biotechnology from Harvard University and University of Rochester, respectively.

Links

Previous companies

Org chart

Manager

Lisa von Moltke

EVP, Chief Medical Officer

Peers

Kelly M. Brady

VP, Clinical Operations

Dennis M Walling

Vice President, Clinical Development, And Head Of Clinical Research

Zahabia Adenwala

Director, Pharmacovigilance Scientist

Reports

Michele Savery

Associate Director, Manufacturing Sciences And Technology

Nicole Delehanty

Associate Director, Donor Medical Operations

Timeline

Executive Director, Clinical Research / Clinical Science & Program Lead For Ser-155
February, 2022 - present
Senior Director Clinical Research Clinical Science Program Lead For SER 287 SER 301
February, 2020
Director Clinical Research Clinical Science
October, 2017

View in org chart